-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Spectrum Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Spectrum Pharmaceuticals Inc Operating Income (Loss) for the quarter ending March 31, 2023 was -$4.87M, a 65.4% increase year-over-year.
- Spectrum Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending March 31, 2023 was -$63.5M, a 50.4% increase year-over-year.
- Spectrum Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$72.7M, a 50.8% increase from 2021.
- Spectrum Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$148M, a 13% increase from 2020.
- Spectrum Pharmaceuticals Inc annual Operating Income (Loss) for 2020 was -$170M, a 20.6% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)